I
Infant Bacterial Therapeutics AB
STO:IBT B
Infant Bacterial Therapeutics AB
STO:IBT B
Price:
50
SEK
-0.99%
Market Closed
Market Cap:
kr651m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
SE |
|
L
|
Lancaster Resources Inc
CNSX:LCR
|
CA |
|
C
|
Cannlabs Inc
OTC:CANL
|
US |
|
Elcom International Inc
OTC:ELCO
|
US |
|
N
|
Nokian Tyres plc
OTC:NKRKF
|
FI |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of IBT B.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IBT B
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
IBT B Competitors Multiples
Infant Bacterial Therapeutics AB Competitors
Infant Bacterial Therapeutics AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
673.6m SEK | 0 | -10.3 | -7.8 | -7.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.6 | 43.1 | 29.1 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.6 | 16.5 | 10.2 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
